|Articles|September 1, 2018
- Applied Clinical Trials-09-01-2018
- Volume 27
- Issue 9
Applied Clinical Trials, September 2018 Issue (PDF)
Click the title above to open the Applied Clinical Trials September 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Greater Gift's PopUp Star Eventalmost 8 years ago
Can FDA Put Some Heat Back Under European Adaptive Pathways?almost 8 years ago
Next-Generation Clinical Trialsalmost 8 years ago
Clinical Trials In a Dish: A Revolution Beginsalmost 8 years ago
EU’s Status on IDMPalmost 8 years ago
Ensuring High-Quality Data in Complex, In-Home Clinical Trialsalmost 8 years ago
FDA Promotes Surrogate Endpoints, ‘Seamless’ Clinical Trialsalmost 8 years ago
Genetic Testing in Clinical Trials: A New Level of Patient Centricityalmost 8 years ago
Q&A: Clinical Trials Need To Grow In Relevancealmost 8 years ago
Designing and Executing a Gene Testing Counseling and Disclosure ProcessAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Portfolio-Level Recruitment Strategy, Real-Time Burden Sampling, and Platinum-Free Bladder Cancer Therapy
2
Selective Safety Data Collection and the Case for Simpler Trials: Q&A with Rob DiCicco, TransCelerate Biopharma
3
ACT Brief: Organizational Barriers to Programmatic Recruitment, Scaling Selective Safety Data Collection, and Subcutaneous Alzheimer's Treatment
4
FDA Finalizes Guidance on Clinical Trial Design for Psychedelic Drug Development
5